Cited by — Impact of PD ‐1 Inhibitor Timing Relative to Locoregional Therapy on Outcomes in uHCC Treated With Lenvatinib‐Based Triple Therapy | ResearchHub - ResearchHub
Research graph
Cited by
Admitted local publications that cite Impact of PD ‐1 Inhibitor Timing Relative to Locoregional Therapy on Outcomes in uHCC Treated With Lenvatinib‐Based Triple Therapy.
No admitted local citation edges point to this work yet.
